Defend with Profend® nasal antiseptic kit to help reduce bacteria on the skin that may cause infection.

Profend_Nasal-Antiseptic_Kit_swabs_513x446_022025_nobackground Click here for a free sample of Profend

60-second application with Profend nasal antiseptic swabs reduces 99.7% of Staphylococcus aureus at 10 minutes and 99% at 12 hours1

A Simple Intervention for High-Risk Patients During High-Risk Periods

Profend PVP-Iodine nasal swabs take just 60 seconds reduce bacteria on the skin that may cause infection.

Visit product page

A quick, comfortable swab designed to fit into pre-surgical care routines.

More on comfort and compliance

Administer as needed to help reduce the risk of bacteria associated with CLABSIs2†

See CDC Prevention Strategies

Easy and efficient—just snap and swab.

  • Profend nasal antiseptic kits come in boxes of 4 swabs—use each swab for 15 seconds for a total of 60 seconds
  • Profend swabs are pre-saturated, mess-free—just snap open and use
  • More than 90% of healthcare providers surveyed prefer Profend kits over other PVP-Iodine products because they can be applied up to 2.5x faster3

Designed for comfort and compliance.

  • Profend nasal swabs have a slim, compact design for patient comfort
  • 96.6% of patients surveyed are comfortable with nasal application of PVP-Iodine4
  • Clinician-administered for increased compliance

Nasal Decolonization is Part of A New Standard of Care

Reducing the presence of S. aureus among patients has been shown to reduce HAIs, length of stays and costs5
Nasal decolonization with PVP-I is now a CDC core strategy.2
As a PVP-Iodine antiseptic rather than an antibiotic Profend kits support your initiatives against antibiotic resistance6
Profend_Nasal-Antiseptic_Kit_swabs_660x750_022025_nobackground

References

1.PDI in vivo Study 0113-CTEVO. 2.Centers for Disease Control and Prevention. Strategies to Prevent Hospital-onset Staphylococcus aureus Bloodstream Infections in Acute Care Facilities. https://www.cdc.gov/hai/prevent/staph-prevention-strategies.html. Published December 2019. Accessed December 10, 2020. 3.PDI user acceptance study. 4.Maslow J, Hutzler L, Cuff G, Rosenberg A, Phillips M, Bosco J. Patient experience with mupirocin or povidone-iodine nasal decolonization. Orthopedics. 2014;37(6):e576–e581. 5.Nelson R, Samore M, Smith K, et al. Cost-effectiveness of adding decolonization to a surveillance strategy of screening and isolation for methicillin-resistant Staphylococcus aureus carriers. Clin Microbiol Infect. 2010;16(12):1740–1746. 6 VandenBergh MF, Yzerman EP, van Belkum A, Boelens HA, Sijmons M, Verbrugh HA. Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state. J Clin Microbiol. 1999;37:3133–3140.

*Surgical site infections. †Central line-associated bloodstream infections.